<DOC>
	<DOCNO>NCT02242877</DOCNO>
	<brief_summary>The aim study compare effect treatment telmisartan patient systolic BP approximately 12 week start treatment control first time patient isolated systolic hypertension ( ISH ) begin patient systolic/diastolic hypertension ( SDH )</brief_summary>
	<brief_title>TELSYS - TELmisartan Effectiveness Isolated SYStolic Hypertension Versus Systolic/Diastolic Hypertension Patients Aged 55 Older</brief_title>
	<detailed_description />
	<mesh_term>Hypertension</mesh_term>
	<mesh_term>Telmisartan</mesh_term>
	<mesh_term>Hydrochlorothiazide</mesh_term>
	<criteria>Age ≥ 55 , upper limit Patient treat follow 12 month general practitioner ( GP ) Hypertension measure least past 12 month control time inclusion study : isolate systolic hypertension , namely systolic blood pressure ≥ 140 mmHg diastolic blood pressure &lt; 90 mmHg systolic/diastolic hypertension , namely systolic blood pressure ≥ 140 mmHg diastolic blood pressure ≥ 90 mmHg ; systolic blood pressure ≥ 130 diastolic blood pressure ≥ 80 mmHg , patient diabetes chronic renal insufficiency Treatment one antihypertensives remains unchanged month prior collect data Decision GP add telmisartan ( either combination hydrochlorothiazide ( HCTZ ) ) antihypertensive treatment ; decision make treat doctor regardless participation study . The prescription issue normal way , accordance condition set market authorisation Written inform consent patient collect his/her data The patient refuse allow his/her data collect Change antihypertensive treatment month prior collection data Blood pressure control The recommend target value correspond control diastolic systolic blood pressure important disease associate hypertension consequently , order prevent collection process become complicate , data patient severe renal insufficiency proteinuria ≥ 1 g/L collect context study</criteria>
	<gender>All</gender>
	<minimum_age>55 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2014</verification_date>
</DOC>